Stockreport

MoonLake Immunotherapeutics Inks Three-Year Technology Partnership With Komodo Health To Advance Research on Inflammatory Skin and Joint Conditions [Yahoo! Finance]

MoonLake Immunotherapeutics - Class A Ordinary Shares  (MLTX) 
PDF SAN FRANCISCO & ZUG, Switzerland, April 10, 2024 BUSINESS WIRE )--MoonLake Immunotherapeutics ("MoonLake"; Nasdaq: MLTX), a clinical-stage biotechnology company focused [Read more]